A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2015
At a glance
- Drugs Lacosamide (Primary) ; Carbamazepine
- Indications Epilepsy; Essential tremor; Fibromyalgia; Osteoarthritis; Pain; Sleep disorders; Tonic-clonic epilepsy
- Focus Therapeutic Use
- Sponsors UCB Pharma Inc
- 20 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology (AAN), according to a UCB media release.
- 23 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 28 Oct 2013 Planned End Date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.